India, Nov. 20 -- As India aspires to become a $30 trillion to $35 trillion economy by 2047, the pharmaceutical industry is poised to play a critical role in driving economic growth and enhancing public health, as per a latest report by EY Parthenon and Organisation of Pharmaceutical Producers of India (OPPI).

There are three interlinked pillars defining India's pharmaceutical industry: dominance in generics and vaccines, the advancing CRDMO/CDMO sector, and the expansion of Global Capability Centers.

Titled"Fueling innovation, advancing equity: The power of partnerships and digital-first strategies driving Indian pharma's global dominance", the report highlights the transformative journey of India's pharmaceutical sector as it evolves ...